Inventor
TAO WEIKANG
CN52 patents
⚠️ This page may combine multiple inventors who share the name “TAO WEIKANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JIANGSU HENGRUI MEDICINE CO
37 patentsUS10905743B2Feb 2, 2021
Interleukin 15 protein complex
JIANGSU HENGRUI MEDICINE CO9 citations85
US10633375B2Apr 28, 2020
Oxopicolinamide derivative, preparation method therefor and pharmaceutical use thereof
JIANGSU HENGRUI MEDICINE CO6 citations84
US11717559B2Aug 8, 2023
Interleukin 15 protein complex and use thereof
JIANGSU HENGRUI MEDICINE CO2 citations72
US11274142B2Mar 15, 2022
Fusion protein containing TGF-β receptor and medicinal uses thereof
JIANGSU HENGRUI MEDICINE CO3 citations72
US10906905B2Feb 2, 2021
Five-membered heteroaryl ring bridged ring derivative, preparation method therefor and medical use thereof
JIANGSU HENGRUI MEDICINE CO2 citations72
US12202891B2Jan 21, 2025
Antibody capable of binding to thymic stromal lymphopoietin and use thereof
JIANGSU HENGRUI MEDICINE CO2 citations71
US10442793B2Oct 15, 2019
Oxa spiro derivative, preparation method therefor, and applications thereof in medicines
JIANGSU HENGRUI MEDICINE CO2 citations70
US11359021B2Jun 14, 2022
PD-L1 antibody, antigen-binding fragment thereof, and pharmaceutical use thereof
JIANGSU HENGRUI MEDICINE CO2 citations69
US11117898B2Sep 14, 2021
Pyrazolo-heteroaryl derivative, preparation method and medical use thereof
JIANGSU HENGRUI MEDICINE CO3 citations69
US10449250B2Oct 22, 2019
Anti-sclerostin antibody, antigen binding fragment and medical use thereof
JIANGSU HENGRUI MEDICINE CO2 citations69
US11111249B2Sep 7, 2021
Heteroaryl-pyrazole derivative, and preparation method therefor and medical application thereof
JIANGSU HENGRUI MEDICINE CO3 citations66
US12428478B2Sep 30, 2025
Anti-Claudin 18.2 antibody and application thereof
JIANGSU HENGRUI MEDICINE CO1 citations63
US12258394B2Mar 25, 2025
IL-5 antibody, antigen binding fragment thereof, and medical application therefor
JIANGSU HENGRUI MEDICINE CO1 citations62
US11084808B2Aug 10, 2021
Oxopicolinamide derivative, preparation method therefor and pharmaceutical use thereof
JIANGSU HENGRUI MEDICINE CO0 citations62
US10899837B2Jan 26, 2021
B7-H3 antibody, antigen-binding fragment thereof and medical use thereof
JIANGSU HENGRUI MEDICINE CO0 citations62
US10889569B2Jan 12, 2021
Condensed ring group azacyclobutyl triazole derivative, preparation method therefor and use thereof in medicine
JIANGSU HENGRUI MEDICINE CO1 citations62
US12187684B2Jan 7, 2025
Benzimidazole derivatives as modulators of retinoid-related orphan receptor gamma (RORγ) and pharmaceutical use thereof
JIANGSU HENGRUI MEDICINE CO0 citations61
US11512055B2Nov 29, 2022
Benzimidazole derivatives as modulators of retinoid-related orphan receptor gamma (RORγ) and pharmaceutical uses thereof
JIANGSU HENGRUI MEDICINE CO1 citations61
US11981733B2May 14, 2024
LAG-3 antibody, antigen-binding fragment thereof, and pharmaceutical application thereof
JIANGSU HENGRUI MEDICINE CO0 citations60
US11365247B2Jun 21, 2022
IL-5 antibody, antigen binding fragment thereof, and medical application therefor
JIANGSU HENGRUI MEDICINE CO1 citations60
US11345753B2May 31, 2022
TIM-3 antibody, antigen binding fragment thereof, and medicinal uses thereof
JIANGSU HENGRUI MEDICINE CO1 citations60
US11312705B2Apr 26, 2022
Heteroaryl[4,3-C]pyrimidine-5-amine derivative, preparation method therefor, and medical uses thereof
JIANGSU HENGRUI MEDICINE CO1 citations60
US11155617B2Oct 26, 2021
LAG-3 antibody, antigen-binding fragment thereof, and pharmaceutical application thereof
JIANGSU HENGRUI MEDICINE CO0 citations60
US12404323B2Sep 2, 2025
Antibody capable of binding to thymic stromal lymphopoietin and use thereof
JIANGSU HENGRUI MEDICINE CO0 citations59
US12325741B2Jun 10, 2025
Anti-Aβ antibodies and antigen-binding fragments thereof
JIANGSU HENGRUI MEDICINE CO0 citations59
US12258405B2Mar 25, 2025
CD3 antibody and pharmaceutical use thereof
JIANGSU HENGRUI MEDICINE CO1 citations59
US11512129B2Nov 29, 2022
TIGIT antibody, antigen-binding fragment thereof, and medical use thereof
JIANGSU HENGRUI MEDICINE CO0 citations59
US11535633B2Dec 27, 2022
Fused tricyclic heterocycle compounds and therapeutic uses thereof
JIANGSU HENGRUI MEDICINE CO2 citations58
US11247998B2Feb 15, 2022
Piperazine heteroaryl derivative, preparation method therefor and use of same in medicine
JIANGSU HENGRUI MEDICINE CO0 citations52
US12325696B2Jun 10, 2025
Indazole derivative, preparation method therefor, and pharmaceutical application thereof
JIANGSU HENGRUI MEDICINE CO0 citations51
US12162879B2Dec 10, 2024
Pyridopyrimidine derivative, preparation method therefor and medical use thereof
JIANGSU HENGRUI MEDICINE CO0 citations50
US11332492B2May 17, 2022
CD73 inhibitors and therapeutic uses thereof
JIANGSU HENGRUI MEDICINE CO0 citations50
US10899741B2Jan 26, 2021
3,4-bipyridyl pyrazole derivative, and preparation method therefor and medical application thereof
JIANGSU HENGRUI MEDICINE CO0 citations50
US12428428B2Sep 30, 2025
Tricyclic tetrahydroisoquinoline derivative, preparation method therefor and application thereof in medicine
JIANGSU HENGRUI MEDICINE CO0 citations49
US10793643B2Oct 6, 2020
PCSK9 antibody, antigen-binding fragment thereof, and medical application thereof
JIANGSU HENGRUI MEDICINE CO0 citations49
US12428482B2Sep 30, 2025
Anti-PD-1 antibody, antigen-binding fragment thereof and pharmaceutical use thereof
JIANGSU HENGRUI MEDICINE CO0 citations47
US11014904B2May 25, 2021
1,2,4-triazine-3-amine derivative, preparation method therefor, and use thereof in medicine
JIANGSU HENGRUI MEDICINE CO0 citations46
SUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD
5 patentsUS10543284B2Jan 28, 2020
Anti-c-Met antibody and anti-c-Met antibody-cytotoxic drug conjugate and pharmaceutical use thereof
SUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD6 citations80
US10786567B2Sep 29, 2020
Stable anti-PD-1 antibody pharmaceutical preparation and application thereof in medicine
SUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD4 citations72
US11365255B2Jun 21, 2022
PD-1 antibody, antigen-binding fragment thereof, and medical application thereof
SUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD2 citations71
US10815304B2Oct 27, 2020
PD-L1 antibody, antigen-binding fragment thereof and medical application thereof
SUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD3 citations70
US11780923B2Oct 10, 2023
PD-L1 antibody, antigen-binding fragment thereof and medical application thereof
SUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD0 citations59
JIANGSU HENGRUI PHARMACEUTICALS CO LTD
4 patentsUS12227499B2Feb 18, 2025
Fused imidazole derivative, preparation method therefor, and medical use thereof
JIANGSU HENGRUI PHARMACEUTICALS CO LTD4 citations72
US12473279B2Nov 18, 2025
Fused imidazole derivative, preparation method therefor, and medical use thereof
JIANGSU HENGRUI PHARMACEUTICALS CO LTD0 citations60
US12459937B2Nov 4, 2025
Fused imidazole derivative, preparation method therefor, and medical use thereof
JIANGSU HENGRUI PHARMACEUTICALS CO LTD0 citations60
US12590081B2Mar 31, 2026
Fused imidazole derivatives, preparation method and medicinal use thereof
JIANGSU HENGRUI PHARMACEUTICALS CO LTD0 citations50
Shanghai hengrui pharmaceutical co ltd
2 patentsHANSOH SHANGHAI HEALTHTECH CO LTD
1 patentJIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD
1 patentShowing the top 50 of 52 patents by PatentIndex Score.